# Reviva Pharmaceuticals Holdings, Inc.: Form SCHEDULE 13D/A, filed Jan 31, 2025

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: SCHEDULE 13D/A
- Filed: 2025-01-31
- Accepted by EDGAR: Jan 31, 2025, 21:31 ET
- Period: not reported
- Accession: 0001493152-25-004530
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000149315225004530/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000149315225004530/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000149315225004530/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-004530. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.